相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
Loredana Puca et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges
Alessandro Leonetti et al.
CELLULAR ONCOLOGY (2019)
Novel targeted strategies to overcome resistance in small-cell lung cancer: focus on PARP inhibitors and rovalpituzumab tesirine
Robin Van Den Borg et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
Real-world effectiveness and tolerability of small-cell lung cancer (SCLC) treatments: A systematic literature review (SLR)
Manca Povsic et al.
PLOS ONE (2019)
Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges
Orgilmaa Regzedmaa et al.
ONCOTARGETS AND THERAPY (2019)
Current Diagnosis and Management of Small-Cell Lung Cancer
Shuhang Wang et al.
MAYO CLINIC PROCEEDINGS (2019)
Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges
A. Pavan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity
Jianshu Wei et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors
Rachel Grosser et al.
CANCER CELL (2019)
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma
Marissa Spino et al.
CLINICAL CANCER RESEARCH (2019)
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target
Vadim S. Koshkin et al.
CLINICAL CANCER RESEARCH (2019)
Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer
Kentaro Tanaka et al.
LUNG CANCER (2018)
Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1
Junpeng Qi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate
Bilal H. Lashari et al.
DRUGS IN R&D (2018)
IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells
Grazia Carbotti et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
Charles M. Rudin et al.
LANCET ONCOLOGY (2017)
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
Andras Heczey et al.
MOLECULAR THERAPY (2017)
Treatment advances in small cell lung cancer (SCLC)
Saiama N. Waqar et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2
Sayed Shahabuddin Hoseini et al.
ONCOIMMUNOLOGY (2017)
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer
Sai Kiran Sharma et al.
CANCER RESEARCH (2017)
Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing
Ji Li et al.
CANCER CELL (2017)
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Scott J. Antonia et al.
LANCET ONCOLOGY (2016)
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
Laura R. Saunders et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
Mingqian Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Staging small cell lung cancer: Veterans administration lung study group versus international association for the study of lung cancer-what limits limited disease?
P Micke et al.
LUNG CANCER (2002)
分享论文
